LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION

Racionalʹnaâ Farmakoterapiâ v Kardiologii

M. L. Maksimov¹  I. I. Kopchenov²  O. D. Ostroumova³ 

[1] I.M. Setchenov First Moscow State Medical University;I.M. Setchenov First Moscow State Medical University;Moscow State University of Medicine and Dentistry named after A.I. Evdokimov;

关键词: arterial hypertension;    antihypertensive therapy;    calcium antagonists;    lercanidipine;   

DOI  :  10.20996/1819-6446-2013-9-1-79-85

来源: DOAJ

【 摘 要 】

Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine are detailed.

【 授权许可】

Unknown